Cargando…
Established Models and New Paradigms for Hypoxia-Driven Cancer-Associated Bone Disease
The five-year survival rate for primary bone cancers is ~ 70% while almost all cases of secondary metastatic bone cancer are terminal. Hypoxia, the deficiency of oxygen which occurs as the rate of tumour growth exceeds the supply of vascularisation, is a key promoter of tumour progression. Hypoxia-d...
Autores principales: | Cox, Thomas R., Erler, Janine T., Rumney, Robin M. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5805797/ https://www.ncbi.nlm.nih.gov/pubmed/29098360 http://dx.doi.org/10.1007/s00223-017-0352-6 |
Ejemplares similares
-
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
por: Cox, Thomas R., et al.
Publicado: (2011) -
The role of lysyl oxidase, the extracellular matrix and the pre-metastatic niche in bone metastasis()()
por: Gartland, Alison, et al.
Publicado: (2016) -
Purinergic signalling in bone
por: Rumney, Robin M. H., et al.
Publicado: (2012) -
Hypoxia and loss of PHD2 inactivate stromal fibroblasts to decrease tumour stiffness and metastasis
por: Madsen, Chris D, et al.
Publicado: (2015) -
Hypoxia-Inducible Factors and Burn-Associated Acute Kidney Injury—A New Paradigm?
por: Enescu, Dan Mircea, et al.
Publicado: (2022)